Fisher & Paykel Healthcare Corporation Limited has currently suspended its Dividend Reinvestment Plan (DRP) under which eligible shareholders in New Zealand, Australia and the United Kingdom may elect to reinvest all or part of their cash dividends in additional Fisher & Paykel Healthcare ordinary shares free of brokerage charges. The board has determined to suspend the DRP given the company's strong performance over the last few years and reduction of debt so that net cash is now within the target gearing range. As a result, shareholders who have previously elected to participate in the DRP will receive their dividends in cash.
DRP Overview
The DRP Offer Document below explains how the plan operates.
Dividend Reinvestment Plan Offer Document